Events Partner Content 2017 HBA European Leadership Summit Take an active part of the future of healthcare
Views & Analysis Tunnah’s musings: Healthcare convergence at the frontiers of... Paul Tunnah considers how traditional medicine, data and technology are coming together to address health needs.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.